StockData
Vicapsys Life Sciences, Inc. logo

Vicapsys Life Sciences, Inc. (VICP) stock

VICPOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Jan 10, 2025
$0.40+0.00 (0.00%)

Close on Oct 19, 2026Market cap $13.73MP/E –Yield –

Vicapsys Life Sciences operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Vicapsys Life Sciences's operating cash flow for the twelve months ending Sep 30, 2024 was -$125.74K. For fiscal 2023 it was -$417.52K. The highest annual figure on record is -$238.20K in fiscal 2022.

Annual operating cash flow

PeriodPeriod endValueChange
FY2023Dec 31, 2023-$417.52K–
FY2022Dec 31, 2022-$238.20K–
FY2021Dec 31, 2021-$443.97K–
FY2020Dec 31, 2020-$262.90K–
FY2019Dec 31, 2019-$970.26K–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2024Sep 30, 2024-$40.43K–
Q2 FY2024Jun 30, 2024$6.17K–
Q1 FY2024Mar 31, 2024-$9.42K–
Q4 FY2023Dec 31, 2023-$82.05K-2941.2%
Q3 FY2023Sep 30, 2023-$107.41K–
Q2 FY2023Jun 30, 2023-$218.10K–
Q1 FY2023Mar 31, 2023-$9.96K–
Q4 FY2022Dec 31, 2022$2.89K–
Q3 FY2022Sep 30, 2022-$41.08K–
Q2 FY2022Jun 30, 2022-$84.03K–
Q1 FY2022Mar 31, 2022-$115.98K–
Q4 FY2021Dec 31, 2021-$123.25K–
Q3 FY2021Sep 30, 2021-$180.08K–
Q2 FY2021Jun 30, 2021-$69.84K–
Q1 FY2021Mar 31, 2021-$70.81K–
Q4 FY2020Dec 31, 2020-$385–
Q3 FY2020Sep 30, 2020-$3.33K–
Q2 FY2020Jun 30, 2020-$25.96K–
Q1 FY2020Mar 31, 2020-$233.22K–
Q4 FY2019Dec 31, 2019-$246.48K–
Q3 FY2019Sep 30, 2019-$341.70K–
Q2 FY2019Jun 30, 2019-$194.35K–
Q1 FY2019Mar 31, 2019-$187.74K–

More Vicapsys Life Sciences figures

See a number that looks wrong?